Pharmacist Mark Mikhael has lost 50 pounds over the past 12 months using semaglutide formulated by his own company, Olympia Pharmaceuticals. He credits this new class of weight loss drugs for his improved health, including no longer having diabetes and achieving an ideal body weight. Mikhael and other large compounding pharmacies are supplying these drugs to millions of Americans, though the practice is controversial and opposed by major pharmaceutical companies. Click here for article.
Weight Loss Success: Mark Mikhael lost 50 pounds and no longer has diabetes, attributing his success to semaglutide produced by his company.
Compounding Pharmacies: Large compounding pharmacies are supplying semaglutide to up to 2 million Americans, often due to shortages of brand-name drugs.
Pharmaceutical Opposition: Companies like Novo Nordisk and Eli Lilly oppose the compounding of their drugs, citing safety concerns and patent infringement.
FDA Regulation and Oversight: The FDA allows compounding in cases of drug shortages but warns about potential risks, and compounding pharmacies must adhere to strict standards.
Comments